CTCs-derived xenograft development in a triple negative breast cancer case 25 Xuñ, 2018

Visto 0 vez

CTCs-derived xenograft development in a triple negative breast cancer case

Conference


First day focused on the advances related to the diagnosis of diseases.
second day focused on therapies for cancer, neurological or neurodegenerative diseases.
The Symposium brings together more than 200 researchers from Europe and the United States (121 women and 87 men) and comprises a total of 20 papers, ten guest speakers or ten other new researchers, as well as 45 scientific poster sessions.

Dª Thais Pereira Veiga
Oncomet. IDIS, Health Research Institute of Santiago - CIBERONC. Spain